REGISTERED NUMBER: 04502825 (England and Wales)

Strategic Report, Director's Report and

Audited Financial Statements for the Year Ended 31 March 2025

for

Amvale Medical Transport Limited

Page

Company Information

1

Strategic Report

2

Director's Report

4

Report of the Independent Auditors

6

Income Statement

9

Other Comprehensive Income

10

Balance Sheet

11

Statement of Changes in Equity

12

Notes to the Financial Statements

13

DIRECTOR:

M J Godfrey

SECRETARY:

Mrs J L Godfrey-East

REGISTERED OFFICE:

Unit 1 C/D Birkdale Road

South Park Industrial Estate

Scunthorpe

North Lincolnshire

DN17 2AU

REGISTERED NUMBER:

04502825 (England and Wales)

INDEPENDENT AUDITORS:

Xeinadin Audit Limited

8th Floor, Becket House

36 Old Jewry

London

EC2R 8DD

REVIEW OF BUSINESS

Revenue

The results of the company as set out herein show turnover decreasing slightly £16.7m FYE 31.3.24 to £15.4m 31.3.25 however operating profit increased from £1.2m to £1.4m respectively .

The company is always actively seeking new opportunities where we can provide enhanced service capabilities and cost benefits to our customers.

The company has been successful with competitive tenders resulting in a number of secured contracts and overall 80% of the revenue streams are under contract with contract periods up to 3 years.

Business Performance

Over the course of the reported financial year the business continued to provide a high quality service across its spectrum of operations and this is borne out from service user, customer satisfaction surveys and customer specific KPIs.

The business continues with its cost control initiatives which have provided tangible cost reductions.

Continued investment in and increased use of technology providing operational efficiency benefits, reducing transactional processing costs and increasing productivity in back office & reporting functions.

Energy efficiency actions

At year end the number of vehicles that were compliant to EURO6 made up 90% of the total fleet of 354 vehicles. Amvale Medical Transport is all too aware that all businesses generate an environmental impact.

We aim to minimise our impact where possible and we have introduced various initiatives to support our aims which are:

- Working with our ESOS partner to better understand areas in which we can improve

- ESOS Phase 3 Energy Audits that are compliant with ESOS were 96%

- Following the NHS Non emergency patient transport decarbonisation timeline which recommends that from 2023 50% of vehicles used to deliver contracts are of the latest emissions standards Ultra low emissions vehicles (ULEV) or zero emissions vehicles (ZEV) 75% from 2026

- Continued monitoring and reporting of vehicle idling time

- Driver performance scoring. This includes monitoring various areas of driver behaviour and providing awareness and retraining as required

- Improvements in vehicle and asset ppm scheduling

Employees

The board would like to thank all employees for their continued efforts and support to the company, our customers and the service users themselves.

We continue to upskill our employees by way of ad hoc training as well as professional and accredited membership training and we have increasingly utilised the apprenticeship levy scheme to support both internal upskilling and to provide accredited training to new employees.

Regular two way communication with employees takes place in a formal manner through meetings held between the general manager, directors and heads of departments and a minimum of 3 ; maximum 6 employees on a rotating basis to ensure that the business obtain input from a wide base of employees.

ON BEHALF OF THE BOARD:

M J Godfrey - Director

12 September 2025

The director presents his report with the financial statements of the company for the year ended 31 March 2025.

PRINCIPAL ACTIVITY

The principal activity of the company is the provision of ambulance transport, medical courier and SEN transport services

Our operating offices are still located in Grimsby and Scunthorpe (Head office) and our sister company Amvale Scotland Ltd in Glasgow .

The business operates within the CQC regulatory regime where applicable and as a business we are ISO 9001:2015 accredited, a Qualsafe approved training centre, Cyber Essentials Certified and Disability Confident Committed.

The company is proud to work alongside its customers and to have introduced enhanced & bespoke services which have led to a reduction of turnaround times and operating costs for the customer and a greatly improved service user experience.

DIVIDENDS

No interim dividend was paid during the year. The director recommends a final dividend of £1 per share.

The total distribution of dividends for the year ended 31 March 2025 will be £ 20,000 .

DIRECTOR

M J Godfrey held office during the whole of the period from 1 April 2024 to the date of this report.

EMPLOYEES

The company places considerable value on the involvement of its employees and has continued to keep them informed on matters affecting them as employees and on the various factors affecting the performance of the company. This has been achieved through formal and informal meetings, electronic communication and updates and the annual financial statements.

Applications for employment by disabled persons are always fully considered, bearing in mind the abilities of the applicant concerned. In the event of members of staff becoming disabled, every effort is made to ensure that their employment with the company continues and that appropriate support and training is provided. It is the policy of the company that the training, career development and promotion of disabled persons should, as far as possible, be identical to that of other employees.

Overall the company policy for recruitment, selection, remuneration, training, development and promotion are designed to ensure that eligibility is considered on the basis of the aptitudes and abilities of the person concerned and that nobody receives less favourable treatment on any grounds.

STATEMENT OF DIRECTOR'S RESPONSIBILITIES

The director is responsible for preparing the Strategic Report, the Director's Report and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to:

-	select suitable accounting policies and then apply them consistently;

-	make judgements and accounting estimates that are reasonable and prudent;

-	prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS

So far as the director is aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and he has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS

The auditors, Xeinadin Audit Limited will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:

M J Godfrey - Director

12 September 2025

Opinion

We have audited the financial statements of Amvale Medical Transport Limited (the 'company') for the year ended 31 March 2025 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

-	give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its profit for the year then ended;

-	have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

-	have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

-	the information given in the Strategic Report and the Director's Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

-	the Strategic Report and the Director's Report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Director's Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

-	adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

-	the financial statements are not in agreement with the accounting records and returns; or

-	certain disclosures of director's remuneration specified by law are not made; or

-	we have not received all the information and explanations we require for our audit.

Responsibilities of director

As explained more fully in the Statement of Director's Responsibilities set out on pages four and five, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the director is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the company or to cease operations, or has no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Through discussion with management and those charged with governance we gained an understanding of the legal and regulatory framework applicable to the entity and the industry in which it operates and considered the risk of acts by the entity that were contrary to applicable laws and regulations, including fraud. During the engagement team briefing we communicated the identified laws and regulations throughout our team and remained alert to any indications of non-compliance throughout the audit.

We focused on laws and regulations that could give rise to a material misstatement in the financial statements, including, but not limited to, FRS102 (UK GAAP), the Companies Act 2006, tax legislations and industry specific legislation, such as the Care Quality Commission (Register) Regulations 2009. We assessed the extent of compliance with these laws and regulations as part of our procedures on the related financial statement items.

We evaluated management's incentives and opportunities for fraudulent manipulations of the financial statements (including risk of override of controls) and determined that the principal risks were related to management bias in accounting estimates.

Audit procedures undertaken in response to the potential risk relating to irregularities (which include fraud and non-compliance with laws and regulations) comprised of:

- enquiries of management and those charged with governance as to whether the entity complies with such laws and regulations;

- enquiries with the same concerning any actual or potential litigation claims;

- reviewed risk of management override;

- review of journal entries posted with unusual account combinations or posted by senior management;

- reviewing accounting estimates for bias;

- performance of analytical review to identify unexpected movements in account balances which may be indicative of fraud;

- agreeing financial statement disclosures to underlying supporting documentation.

The likelihood of detecting irregularities, including fraud, is limited by the inherent difficulty in detecting irregularities, the effectiveness of the entity's controls, the nature, timing and extent of the audit procedures performed. Irregularities that result from fraud might be inherently more difficult to detect than irregularities that result from error. As explained above, there is an unavoidable risk that material misstatements may not be detected, even though the audit has been planned and performed in accordance with ISAs (UK).

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Mark Stothard BA (Hons) FCA (Statutory Auditor)

for and on behalf of Xeinadin Audit Limited

8th Floor, Becket House

36 Old Jewry

London

EC2R 8DD

12 September 2025

TURNOVER

3

15,432,860

16,719,100

Cost of sales

13,154,283

14,719,130

GROSS PROFIT

2,278,577

1,999,970

Administrative expenses

863,392

796,247

OPERATING PROFIT

5

1,415,185

1,203,723

Interest receivable and similar income

127,930

119,237

1,543,115

1,322,960

Interest payable and similar expenses

6

224,674

124,026

PROFIT BEFORE TAXATION

1,318,441

1,198,934

Tax on profit

7

342,045

344,328

PROFIT FOR THE FINANCIAL YEAR

976,396

854,606

PROFIT FOR THE YEAR

976,396

854,606

OTHER COMPREHENSIVE INCOME

-

-

TOTAL COMPREHENSIVE INCOME FOR THE YEAR

976,396

854,606

FIXED ASSETS

Tangible assets

9

3,754,211

3,533,391

CURRENT ASSETS

Stocks

10

21,297

21,252

Debtors

11

5,531,072

4,775,239

Cash at bank and in hand

2,366,937

2,424,160

7,919,306

7,220,651

CREDITORS

Amounts falling due within one year

12

2,480,601

2,560,257

NET CURRENT ASSETS

5,438,705

4,660,394

TOTAL ASSETS LESS CURRENT LIABILITIES

9,192,916

8,193,785

CREDITORS

Amounts falling due after more than one year

13

(1,293,011

)

(1,368,412

)

PROVISIONS FOR LIABILITIES

17

(326,362

)

(208,226

)

NET ASSETS

7,573,543

6,617,147

CAPITAL AND RESERVES

Called up share capital

18

20,000

20,000

Share premium

19

464,306

464,306

Retained earnings

19

7,089,237

6,132,841

SHAREHOLDERS' FUNDS

7,573,543

6,617,147

The financial statements were approved by the director and authorised for issue on 12 September 2025 and were signed by:

M J Godfrey - Director

Called up

share

Retained

Share

Total

capital

earnings

premium

equity

£

£

£

£

Balance at 1 April 2023

20,000

5,408,235

464,306

5,892,541

Changes in equity

Dividends

-

(130,000

)

-

(130,000

)

Total comprehensive income

-

854,606

-

854,606

Balance at 31 March 2024

20,000

6,132,841

464,306

6,617,147

Changes in equity

Dividends

-

(20,000

)

-

(20,000

)

Total comprehensive income

-

976,396

-

976,396

Balance at 31 March 2025

20,000

7,089,237

464,306

7,573,543

1.	STATUTORY INFORMATION

Amvale Medical Transport Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Financial Reporting Standard 102 - reduced disclosure exemptions

The company has taken advantage of the following disclosure exemption in preparing these financial statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":

•

the requirements of Section 7 Statement of Cash Flows.

Related party exemption

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Significant judgements and estimates

In applying the company's accounting policies set out below management is required to make certain estimates and judgements concerning the future. These judgements are regularly reviewed and updated as necessary. The estimates and judgements that have most significant effect on the amounts included in these financial statements are as follows:

- Useful lives of plant and equipment

Depreciation is provided so as to write down the assets to their residual values over their estimated useful lives as set out in the company's accounting policy. The selection of these estimated useful lives requires the exercise of management judgement. Useful lives are regularly reviewed and should management's assessment of useful lives shorten then depreciation charges in the financial statements would increase and carrying amounts of property, plant and equipment would reduce accordingly.

- Trade debtors

The company reviews the reconcilability of trade debtors and makes allowances for doubtful debts where considered appropriate. If there is evidence of impairment the carrying amount of the debtor is reduced to its recoverable amount. The impairment loss is recognised immediately in the income statement.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts, rebates, and value added tax and other sales taxes. Turnover includes revenue earned from the rendering of services.

Turnover from the rendering of services is recognised by reference to the stage of completion of the contract and based on the timing of the services performed.

Tangible fixed assets

Tangible fixed assets are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. The company adds to the carrying amount of an item of fixed assets the cost of replacing part of such an item when the cost is incurred if the replacement part is expected to provide incremental future benefits to the company. The carrying amount of the replaced part is derecognised.

Repairs and maintenance are charged to the income statement during the period in which they are incurred.

Depreciation is provided to write off the cost, less estimated residual values, of all tangible fixed assets, except for freehold land, evenly over their expected useful lives. It is calculated at the following rates:

Plant and machinery

-

25% on reducing balance

Motor vehicles

-

20% on cost

Fixtures and fittings

-

15% on reducing balance

Computer equipment

-

25% on reducing balance

Freehold Property

-

2% on cost

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the income statement.

Stocks

Stocks are valued at the lower of cost and estimated selling price less costs to complete and sell, after making due allowance for obsolete and slow moving items. Cost is calculated on an average cost basis.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they are paid.

Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The directors therefore continue to adopt the going concern basis of accounting in preparing the financial statements.

Impairment of assets

At each reporting date fixed assets are reviewed to determine whether there is any indication that those assets have suffered an impairment loss. If there is an indication of possible impairment, the recoverable amount of any affected asset is estimated and compared with its carrying amount. If estimated recoverable amount is lower, the carrying amount is reduced to its estimated recoverable amount, and an impairment loss is recognised in profit or loss.

If an impairment loss subsequently reverses, the carry amount of the asset is increased to the revised estimate of its recoverable amount, but not in excess of the amount that would have been determined had no impairment loss been recognised for the asset in prior years. A reversal of an impairment loss is recognised immediately in profit or loss.

3.

TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the company.

An analysis of turnover by class of business is given below:

31.3.25

31.3.24

£

£

Ambulance and mental health

7,380,366

8,777,489

Transplant and other sales

793,873

2,040,794

School transport

7,258,621

5,900,817

15,432,860

16,719,100

4.	EMPLOYEES AND DIRECTORS

31.3.25

31.3.24

£

£

Wages and salaries

8,500,545

8,941,719

Social security costs

702,494

724,290

Other pension costs

148,180

604,828

9,351,219

10,270,837

The average number of employees during the year was as follows:

31.3.25

31.3.24

Management and administration

13

17

Ambulance station and control staff

13

12

Paramedics and technicians

120

142

SEN staff

300

328

446

499

31.3.25

31.3.24

£

£

Director's remuneration

59,768

26,710

5.	OPERATING PROFIT

The operating profit is stated after charging/(crediting):

31.3.25

31.3.24

£

£

Hire of plant and machinery

416,335

460,591

Other operating leases

157,342

118,523

Depreciation - owned assets

349,905

632,909

Depreciation - assets on hire purchase contracts

627,506

299,424

Profit on disposal of fixed assets

(190,414

)

(165,126

)

Auditors' remuneration

14,000

13,650

Auditors' remuneration for non audit work

14,827

4,494

6.

INTEREST PAYABLE AND SIMILAR EXPENSES

31.3.25

31.3.24

£

£

Bank loan interest

17,493

16,123

Hire purchase

207,181

107,903

224,674

124,026

7.

TAXATION

Analysis of the tax charge

The tax charge on the profit for the year was as follows:

31.3.25

31.3.24

£

£

Current tax:

UK corporation tax

223,908

283,669

Deferred tax

118,137

60,659

Tax on profit

342,045

344,328

Reconciliation of total tax charge included in profit and loss

The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

31.3.25

31.3.24

£

£

Profit before tax

1,318,441

1,198,934

Profit multiplied by the standard rate of corporation tax in the UK of 25% (2024 - 25%)

329,610

299,734

Effects of:

Expenses not deductible for tax purposes

9,833

1,745

Depreciation in excess of capital allowances

5,244

42,849

Group relief

(2,642

)

-

Total tax charge

342,045

344,328

8.

DIVIDENDS

31.3.25

31.3.24

£

£

Interim

20,000

130,000

9.	TANGIBLE FIXED ASSETS

Fixtures

Freehold

Plant and

and

property

machinery

fittings

£

£

£

COST

At 1 April 2024

941,887

610,052

87,716

Additions

-

17,988

1,700

Disposals

-

-

-

At 31 March 2025

941,887

628,040

89,416

DEPRECIATION

At 1 April 2024

23,607

407,251

62,938

Charge for year

18,838

54,447

3,738

Eliminated on disposal

-

-

-

At 31 March 2025

42,445

461,698

66,676

NET BOOK VALUE

At 31 March 2025

899,442

166,342

22,740

At 31 March 2024

918,280

202,801

24,778

Motor

Computer

vehicles

equipment

Totals

£

£

£

COST

At 1 April 2024

6,733,167

144,353

8,517,175

Additions

1,349,526

6,612

1,375,826

Disposals

(822,816

)

-

(822,816

)

At 31 March 2025

7,259,877

150,965

9,070,185

DEPRECIATION

At 1 April 2024

4,398,158

91,830

4,983,784

Charge for year

886,448

13,940

977,411

Eliminated on disposal

(645,221

)

-

(645,221

)

At 31 March 2025

4,639,385

105,770

5,315,974

NET BOOK VALUE

At 31 March 2025

2,620,492

45,195

3,754,211

At 31 March 2024

2,335,009

52,523

3,533,391

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Motor

vehicles

£

COST

At 1 April 2024

3,022,811

Additions

1,146,747

Transfer to ownership

(563,244

)

At 31 March 2025

3,606,314

DEPRECIATION

At 1 April 2024

885,378

Charge for year

627,506

Transfer to ownership

(293,372

)

At 31 March 2025

1,219,512

NET BOOK VALUE

At 31 March 2025

2,386,802

At 31 March 2024

2,137,433

10.

STOCKS

31.3.25

31.3.24

£

£

Stocks

21,297

21,252